# Examination of the Metabolic Effects of Direct Bile Salt Delivery to the Ileum in Humans

> **NCT03201952** · PHASE1 · TERMINATED · sponsor: **Vanderbilt University Medical Center** · enrollment: 2 (actual)

## Conditions studied

- Glucose Intolerance
- Gastric Bypass Surgery

## Interventions

- **DRUG:** Ursodeoxycholic Acid
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT03201952
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-02-01
- **Primary completion:** 2020-05-01
- **Final completion:** 2020-05-01
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Difficulty in participant recruitment
- **Last updated:** 2021-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03201952

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03201952, "Examination of the Metabolic Effects of Direct Bile Salt Delivery to the Ileum in Humans". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03201952. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*